Bosulif is authorized in Europe for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) who
The 3500xL Dx is an automated 24 capillary-based Sanger Sequencer designed to deliver high quality performance, higher throughput and increased productivity for clinical laboratories around the world. The
Tecfidera reduces relapses and development of brain lesions, to slow disability progression over time. The FDA approval of Tecfidera was based on two global phase 3 studies, DEFINE
The 18,000m² facility earlier obtained manufacturing approval and cGMP certification from the RP Tuebingen, Germany. Vetter managing director Thomas Otto said, "We at Vetter work diligently to meet
The approval was based on positive data from multicenter, double-blind trial conducted in 127 pediatric patients between one to 11 years of age with GERD. Eisai president and
On 15 July 2011, the US Food and Drug Administration (FDA) had approved the product. As part of the agreement, Aptalis will produce and supply the product to
Diphenhydramine Hydrochloride Injection, USP, is an injectable antihistamine effective in adults and pediatric patients excluding infants and neonates. BD executive vice president and chief operating officer William Kozy
Ospemifene is developed as as vulvar and vaginal atrophy (VVA) therapy in post-menopausal women. Shionogi CEO Takashi Takenoshita said the US Food and Drug Administration has approved ospemifene
Life Technologies’ lentiviral vector technology will be leveraged in the development of next generation upcyte cells for biopharma and academic research markets. Medicyte CEO Dr. Joris Braspenning said,
The application includes safety and efficacy data of the investigational sublingual dissolvable tablet from Phase III trials including a long-term, multi-season trial. Merck Research Laboratories senior vice president,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.